Avalere (page inactive) retweeted
Navigating uncertainty: redefining healthcare value in an evolving healthcare landscape @avalere @avalerehealth evidencebaseonline.com/navig…
Avalere (page inactive) retweeted
Navigating uncertainty: redefining #healthcare value in an evolving healthcare landscape @avalere @avalerehealth evidencebaseonline.com/navig…
Avalere (page inactive) retweeted
A new white paper from @avalere examines the future opportunities and current challenges related to adult combination vaccines in development, highlighting the need for alignment on strain selection, coverage and more. Full report: buff.ly/44SYzcA
Avalere (page inactive) retweeted
Adult combo #vaccines promise streamlined protection against respiratory diseases like #flu & #COVID19 and improved uptake. But a new report from @avalere points to several barriers that must be addressed to ensure uninterrupted patient access. Learn more: bit.ly/4dqme8n
Avalere (page inactive) retweeted
A new white paper from @avalere examines the future opportunities and current challenges related to adult combination vaccines in development, highlighting the need for alignment on strain selection, coverage and more. Read the full report: bit.ly/4dqme8n
Avalere (page inactive) retweeted
Report by @avalere finds the proposal to “stack” drug discounts in calculating Medicaid best price could lead to disruption for patients, pharmacies, payers, and manufacturers. Learn more: hlc.org/news/analysis-propos…
Avalere (page inactive) retweeted
Cardiovascular therapies may require longer, larger clinical trials than other medicines and developing them is often more complex. A new @avalere whitepaper shows how the IRA's pill penalty could make development of these medicines even harder.
Read more: avalere.com/insights/ira-dru…
To assess the potential implications of negotiation on the #CVD landscape, @advcardiohealth
commissioned us to analyze the unique dynamics facing CVD drug development and how the #IRA may affect development decisions and timelines. Read our findings: avalere.com/insights/ira-dru…
Avalere (page inactive) retweeted
New @avalere Report Raises Key Questions About the #InflationReductionAct Impact on Cardiovascular Drug Development 👉 brnw.ch/21wE1wR
#IRA #cardiovascular
Avalere (page inactive) retweeted
📣 New #Medicare reform analysis from @Avalere
Building on their initial research earlier this year, this new study—sponsored by PAN—spotlights the continued affordability challenges facing individuals enrolled in #MedicarePartD, despite historic reforms. panfoundation.org/new-analys…

ALT Beige background with a large pink donut graph on the far left side of the graphic showing 25% in purple. On the right of the chart is purple superheader text, "NEW ANALYSIS" Below in gray text, "Medicare reforms will lead to continued affordability challenges, despite increased medication uptake and adherence." Below in light gray, "Avalere, 2023"
Avalere (page inactive) retweeted
We’re one week out from @STATnews’ #STATSummit! Join @KLHagan, Kelly Brantley of @Avalere, and patient advocate, George Valentine, virtually or in Boston next week.
statnews.com/2023/summit/sta…
📢 Be the first to hear findings from a new analysis exploring how historic #Medicare Part D reforms could change adherence to treatment at @STATnews’ #STATSummit.
Join @KLHagan, Kelly Brantley (@Avalere) and patient advocate, George Valentine, on 10/18: statnews.com/2023/summit/sta…
Avalere (page inactive) retweeted
How does Washington influence access and affordability? Scott and Mark talk to Lance Grady, Executive Vice President of @avalere about how Washington’s decisions will shape the future of patient access.
prescriptionforbetteraccess.…
Avalere (page inactive) retweeted
An analysis of physician payments conducted for COA by @avalere examining reimbursement trends finds that payment amounts for high-volume oncology services are generally the same or lower than they were a decade ago.
ow.ly/1hxe50PTsrg
Avalere (page inactive) retweeted
Welcome to U.S. Business Action to End HIV @avalerehealth, @Biostaxcorp, @Mercer_US, @mtl_social, @ParamountPics, and @pfizer!
We are excited to have you join and commit to accelerating progress on ending HIV.
Learn more at healthaction.org/whatsnew/06…
Avalere (page inactive) retweeted
Couldn’t endorse this amazing program more! If you have an advanced degrees you’re interested in health policy/ market access, you should apply to @avalerehealth’s FDA Fellowship. I’d be glad to share about my experience. fishawackhealth.applytojob.c…
Avalere (page inactive) retweeted
Today at @Asembia’s #AXS23, @KLHagan, PAN President and CEO, joined Carmine DeNardo (@Omnicell) and Kelly Brantley (@Avalere Health) for an insightful conversation on the continued need for charitable patient assistance. (1/2)

ALT Carmine DeNardo, Kelly Brantley, and Kevin L. Hagan sitting on stage behind a long rectangular table at their Asembia 2023 panel. Lower third purple banner with white text, "Post-Inflation Reduction Act: The Continued Need for Charitable Patient Assistance with Carmine DeNardo, Kelly Brantley, and Kevin L. Hagan #AXS23"
Avalere (page inactive) retweeted
The Inflation Reduction Act is “probably the biggest change in payment policy for drugs covered by Medicare,” speakers said during Asembia’s AXS23 Summit. specialtypharmacycontinuum.c… @avalerehealth @asembiarx #AXS23 #Asembia2023 #AsembiaSummit2023 #Asembia23
Avalere (page inactive) retweeted
Are you attending @asembiarx’s #AXS23? Our President and CEO, @KLHAGAN will be speaking with Kelly Brantley (@avalerehealth) and Carmine DeNardo (@Omnicell) on the continued need for patient assistance.
Learn more & join us on May 3 at 8 am PT: https://teapawt.org/t.co/yjZVdaXmeY #Asembia23
Avalere (page inactive) retweeted
RSVP to HWS: Unpacking the Controversy over Medicare Advantage. Join moderator @larry_levitt tomorrow as he discusses a range of issues about the rapidly growing Medicare private plan option with experts @jeanniebin, @TKornfield, and Richard Kronick. kff-org.zoom.us/webinar/regi…
Avalere (page inactive) retweeted
Join me and three top notch experts -- @jeanniebin, @TKornfield, and Rick Kronick -- as we unpack the controversy over Medicare Advantage.
Join the event and ask questions, or reply with things you want to know.
kff-org.zoom.us/webinar/regi…
Avalere (page inactive) retweeted
Roses are red;
Violets are blue.
The #EOM may seem complex,
That is why @avalerehealth is here for you!
#HealthPolicyValentines























